THE FDA HAS AUTHORIZED FOUR NEW NICOTINE POUCHES THROUGH THE PREMARKET TOBACCO PRODUCT APPLICATION PATHWAY, SAYING ITS EVALUATION FOUND THE NEW PRODUCTS CONTAIN LOWER LEVELS OF MOST HPHCS VERSUS

OTHER ORAL AND SMOKELESS TOBACCO PRODUCTS, AND THAT IT HAS BEGUN IMPLEMENTING EFFICIENCIES LEARNED FROM THE PILOT IN ITS REVIEW OF OTHER PMTAS

متن اصلی؛ ترجمهٔ فارسی ندارد